Margaret Denise Mills, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Broadway Rd, Suite 6, Dracut, MA 01826 Phone: 978-458-0475 Fax: 978-458-3574 |
Catherine Njoki Macharia, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 53 Vermont Ave, Dracut, MA 01826 Phone: 978-732-8398 |
Joseph M. Dulac, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1595 Bridge St, Suite 3, Dracut, MA 01826 Phone: 978-323-2808 Fax: 978-323-2810 |
Dr. Nasim Ghaffar, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 505 Nashua Rd, Dracut, MA 01826 Phone: 978-957-4474 Fax: 978-957-4475 |
Pardeep Aujla, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1595 Bridge St Unit 3, Dracut, MA 01826 Phone: 978-323-2808 Fax: 978-323-2810 |
Dr. Chong So, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1595 Bridge St, #3, Dracut, MA 01826 Phone: 978-323-2808 Fax: 978-323-2810 |
News Archive
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI 61 trial presented today in a Hot Line Session at ESC Congress and published in the New England Journal of Medicine.
A new article explores the pathophysiological factors that link sleep disturbances and Alzheimer's disease.
Researchers at the Karolinska Institutet, Sweden, have made an important discovery about a poorly understood group of immune cells (mucosa-associated invariant T [MAIT]cells) that could improve understanding of what happens during the initial stages of HIV infection.
Researchers at the University of Oslo have made discoveries that can have great consequences for the treatment of blindness caused by so-called limbal stem cell deficiency.
› Verified 1 days ago